Published in Gene Therapy Weekly, April 20th, 2006
"Livin (alternatively called ML-IAP or KIAP) is a cancer-associated member of the antiapoptotic inhibitor of apoptosis protein family. Two splicing variants of Livin, designated Livin alpha and Livin beta, have been identified," wrote I. Crnkovic-Mertens and colleagues, Deutsch Krebsforschungszentrum.
They continued, "The significance of these isoforms for Livin-mediated apoptosis inhibition is largely unclear. Using...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.